tetano
Editor, Senior Moderator
Prim Care Diabetes. 2019 Sep 30. pii: S1751-9918(19)30327-4. doi: 10.1016/j.pcd.2019.09.004. [Epub ahead of print] [h=1]Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients.[/h]
Moreno-Fern?ndez J[SUP]1[/SUP], Garc?a-Seco JA[SUP]2[/SUP], Rodrigo EMO[SUP]3[/SUP], Segura AMS[SUP]2[/SUP], Garc?a-Seco F[SUP]4[/SUP], Mu?oz-Rodr?guez JR[SUP]5[/SUP].
[h=3]Author information[/h] 1 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es. 2 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. 3 Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain. 4 C?rdoba Medicine School, C?rdoba University, C?rdoba, Spain. 5 Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.
[h=3]Abstract[/h] [h=4]AIM:[/h] To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.
[h=4]MATERIALS AND METHODS:[/h] Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.
[h=4]RESULTS:[/h] Three hundred patients were analyzed (male 53%). Mean age was 40.0?14.4years and T1DM duration was 19.7?11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.
[h=4]CONCLUSIONS:[/h] The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
Copyright ? 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] HBV; Influenza; Pneumococcal; Type 1 diabetes; Vaccination
PMID: 31582202 DOI: 10.1016/j.pcd.2019.09.004
Moreno-Fern?ndez J[SUP]1[/SUP], Garc?a-Seco JA[SUP]2[/SUP], Rodrigo EMO[SUP]3[/SUP], Segura AMS[SUP]2[/SUP], Garc?a-Seco F[SUP]4[/SUP], Mu?oz-Rodr?guez JR[SUP]5[/SUP].
[h=3]Author information[/h] 1 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es. 2 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. 3 Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain. 4 C?rdoba Medicine School, C?rdoba University, C?rdoba, Spain. 5 Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.
[h=3]Abstract[/h] [h=4]AIM:[/h] To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.
[h=4]MATERIALS AND METHODS:[/h] Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.
[h=4]RESULTS:[/h] Three hundred patients were analyzed (male 53%). Mean age was 40.0?14.4years and T1DM duration was 19.7?11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.
[h=4]CONCLUSIONS:[/h] The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
Copyright ? 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] HBV; Influenza; Pneumococcal; Type 1 diabetes; Vaccination
PMID: 31582202 DOI: 10.1016/j.pcd.2019.09.004